Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Rally Foundation
Grant: 20CDN46
V Foundation for Cancer Research
Grant: V2022-008
Vince Lombardi Cancer Foundation
Grant: N/A
American Cancer Society
Grant: IRG-19-137-20
National Cancer Institute
Grant: T32 CA009686
National Institute of Neurological Disorders and Stroke
Grant: R01NS110591,NS118023,K01NS119351
National Cancer Institute
Grant: R00 CA241367
SREB
Grant: SC15321
Medical University of South Carolina - College of Graduate Studies
Grant: Odyssey
Hollings Cancer Center, Medical University of South Carolina
Grant: Lowvelo Graduate Fellowship
Hollings Cancer Center, Medical University of South Carolina
Grant: Lowvelo Postdoctoral Fellowship
Foundation for the National Institutes of Health
Grant: P30CA046934
National Cancer Institute
Grant: CA-096832
National Cancer Institute
Grant: CA-21765
Alex Lemonade Stand Foundation
Grant: 23-28298
NCI NIH HHS
Grant: P01 CA096832
NCI NIH HHS
Grant: P30 CA138313
NCI NIH HHS
Grant: K01 CA245231
NINDS NIH HHS
Grant: R01 NS110591
NINDS NIH HHS
Grant: K01 NS119351
NCI NIH HHS
Grant: P30 CA021765
NINDS NIH HHS
Grant: R01 NS118023
National Institutes of Health
Grant: 3P30CA021765-41S2
Cancer Center Support Grant (CCSG)
National Institutes of Health
Grant: 5R01NS118023-05
Epigenetic pathways and cell cycle exit
National Institutes of Health
Grant: 5R01NS110591-04
Novel regulators of Gli-driven medulloblastoma
National Institutes of Health
Grant: 4R00CA241367-03
Genetics of Tumor Suppression by p53
National Institutes of Health
Grant: 5P01CA096832-07
Normal &Neoplastic Growth in the Brain
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3T32CA009686-05S1
TRAINING GRANT IN TUMOR BIOLOGY
National Institutes of Health
Grant: 5P30CA138313-09
Medical University of South Carolina - Cancer Center Support Grant
National Institutes of Health
Grant: 5K01NS119351-03
Identifying Novel Therapeutics for High Risk Medulloblastoma Patients
Fields of Study
MeSH Terms
Keywords